HealthPadTalks: Phase-0: The Trial Before the Failure


90% of drug candidates die before they ever matter - the “Valley of Death.” This episode of HealthPadTalks goes to the failure point most pipelines avoid: Phase-0. We explore how microdosing, ultra-sensitive measurement, and AI-designed molecules turn early clinical insight into human truth - so teams make smarter calls, protect patients, and stop burning capital.

Comments